Cell Membrane Molecules on Neoplastic Cells: Their Role in Malignant Cell Transformation and Dissemination

  • Lennart Olsson
  • Claus Due
Part of the NATO ASI Series book series (NSSA, volume 113)


Malignant, neoplastic cell populations are characterized by their autonomous growth, invasiveness and metastatic activity. These features, like normal cellular activities, are all dependant on the interaction between the cells and their microenvironment. The cell membrane therefore constitutes a crucial biological structure in neoplastic cell behaviour.


Athymic Nude Mouse Carbohydrate Epitope Metastatic Activity Autonomous Growth Squamous Lung Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.R. Gabin, P. Gordon, J. Ruth, J.A. Archer and D.N. Buell, Characteristics of the human lymphocytes insulin receptor, J. Biol. Chem. 248:2202 (1973).Google Scholar
  2. 2.
    S. Jacobs and P. Cuatrecasas, Insulin receptor structure and function, Endocrine Rev. 2:251 (1981).CrossRefGoogle Scholar
  3. 3.
    H.O. McDevitt, Current concepts in immunology: Regulation of the immune response by the major histocombatibility system, N. Engl. J. Med. 303:1514 (1980).CrossRefGoogle Scholar
  4. 4.
    L. Hood, M. Steinmetz and B. Mulissen, Genes of the major histocompatibility complex of the mouse, Ann. Rev. Immunol. 1:529 (1983).CrossRefGoogle Scholar
  5. 5.
    J. Lotem and L. Sachs, Regulation of normal differentiation in mouse and human myeloid leukemia cells by phorbol ester and the mechanism of tumor promotion, Carcinog. Compr. Surv. 7:385 (1982).Google Scholar
  6. 5.
    R.W. Schroff, K.A. Foon, R.J. Billing and J.L. Fahey, Immunologie classification by lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens, Blood 59:207 (1982).Google Scholar
  7. 6.
    A.J. McMichal and J.W. Fabre (eds), “Monoclonal antibodies in clinical medicine.” Academic Press, London (1982).Google Scholar
  8. 7.
    M.S. Mitchell and H.F. Oettgen, Hybridomas in cancer diagnosis and treatment, Prog. Cancer Res. Ther. 21:1 (1982).Google Scholar
  9. 8.
    R.J. Cohen and H.N. Eisen, Hypothesis: Interaction of macromolecules on cell membranes and restriction of T-cell specificity by products of the major histocompatibility comples, Cell Immunol. 32:1 (1977).CrossRefGoogle Scholar
  10. 10.
    M. Simonsen and L. Olsson, Possible roles of compound receptors in the immune system, Ann. Immunol. 134D:85 (1983).Google Scholar
  11. 11.
    M. Simonsen, C. Skjødt and M. Crone, Compound receptors in the cell membrane: Ruminations from the borderland of immunology and physiology, Prog. Allergy 36:151 (1985)Google Scholar
  12. 12.
    L. Olsson, Human monoclonal antibodies in experimental cancer research, J. Natl. Cancer Inst., in press.Google Scholar
  13. 13.
    L. Old, Cancer immunology: The search for specificity, Cancer Res. 41:361 (1981).Google Scholar
  14. 14.
    S. Ohno, The original function of MHC antigen as the general plasma membrane anchorage site of organogenesis-directing proteins. Immunol. Rev., 33:59 (1977).CrossRefGoogle Scholar
  15. 15.
    V. Ginsburg, P. Fredman and J. Magnani, Cancer associated carbohydrated antigens detected by monoclonal antibodies, Contrib. Oncol. 19:51 (1984).Google Scholar
  16. 16.
    S. Hakamori and R. Kannagi, Glycosphingolipids as tumor-associated and differentiation markers, J. Natl. Cancer Inst. 71:231 (1983).Google Scholar
  17. 17.
    T. Feizi, Demonstration and glycolipids are onco-developmental antigens, Nature 314:53 (1985).CrossRefGoogle Scholar
  18. 18.
    P.C. Nowell, The clonal evolution to tumor cell populations, Science 194:23 (1976).CrossRefGoogle Scholar
  19. 19.
    G. Poste and I.J. Fidler, The pathogenesis of cancer metastasis, Nature 283:139 (1980).CrossRefGoogle Scholar
  20. 20.
    G.H. Heppner, Tumor heterogeneity, Cancer Res. 44:2259 (1984).Google Scholar
  21. 21.
    L. Olsson, Phenotypic diversity in leukemia cell population, Cancer Metastasis Rev. 2:153 (1983).CrossRefGoogle Scholar
  22. 22.
    A.D. Riggs and P.A. Jones, 5-methylcytosine, gene regulation and cancer, Adv. Cancer Res. 40:1 (1983).CrossRefGoogle Scholar
  23. 23.
    P.A. Jones, Altering gene expression with 5-azacytidine, Cell 40:485 (1985).CrossRefGoogle Scholar
  24. 24.
    L. Olsson, C. Due and M. Diamant, Treatment of human cell lines with non-mutagenic, non-toxic doses of 5-azacytidine may result in profound alterations in clonogenicity and growth rate, J. Cell. Biol. 100:108 (1985).CrossRefGoogle Scholar
  25. 25.
    L. Ossowski and E. Reich, Changes in malignant phenotype of a human carcinoma conditioned by growth environment, Cell 33:323 (1983).CrossRefGoogle Scholar
  26. 26.
    C. Honsik, M. Diamant and L. Olsson, Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment, Submitted.Google Scholar
  27. 27.
    L. Chatenaud and J.F. Bach, Antigenic modulation — a major mechanism of antibody action, Immunol. Today 5:20 (1984).Google Scholar
  28. 28.
    M.D. Waterfield, G.T. Scarce and N. Whittle, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of Simian sarcoma virus, Nature 304:35 (1983).CrossRefGoogle Scholar
  29. 29.
    R.F. Doolittle, M.W. Hunkapilar and L. Hood, Simian sarcoma virus onc-gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor, Science 221:275 (1983).CrossRefGoogle Scholar
  30. 30.
    T. Hunter, Oncogenes and proto-oncogenes: How do they differ? J. Natl. Cancer Inst. 73:773 (1984).Google Scholar
  31. 31.
    T. Burgess, Growth factors and oncogenes, Immunol. Today 6:107 (1985).CrossRefGoogle Scholar
  32. 32.
    A. Ullrich, L. Cousseus and J.S. Hayflink, Human epidermal growth factor receptor. DNA sequence and oberrant expression of the amplified gene in A431 epidernoid carcinoma cells, Nature 309:18 (1984).CrossRefGoogle Scholar
  33. 33.
    L. Olsson and J. Forchhammer, Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine and characterization of an antigen associated with metastatic activity, Proc. Natl. Acad. Sci USA 81:7897 (1984).CrossRefGoogle Scholar
  34. 34.
    I.R. Hart, Molecular basis of tumour spreads, Nature 315:274 (1985).CrossRefGoogle Scholar
  35. 35.
    R.A. Miller, D.G. Maloney, R. Warnke and R. Levy, Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody, N. Engl. J. Med. 306:517 (1982).CrossRefGoogle Scholar
  36. 36.
    R. Levy and R.A. Miller, Biological and clinical implications of lymphocyte hybridomas: Tumor therapy with monoclonal antibodies, Ann. Rev. Med. 34:107 (1983).CrossRefGoogle Scholar
  37. 37.
    H. Koprowski, D. Herlyn and M. Lubeck, Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?, Proc. Natl. Acad. Sci. USA 81:216 (1984).CrossRefGoogle Scholar
  38. 38.
    G.T. Nepom, U.T. Nelson and S.L. Holbeck, Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice, Proc. Natl. Acad. Sci USA 81:2864 (1984).CrossRefGoogle Scholar
  39. 39.
    L. Olsson, H.R. Sørensen and O. Behnke, Intratumoral phenotypic diversity of cloned human lung tumor cell lines and consequences for analysis with monoclonal antibodies, Cancer 54:1757 (1984).CrossRefGoogle Scholar
  40. 40.
    L Olsson, O. Behnke and H.R. Sørensen, Modulatory effects of 5-azacytidine, phorbol ester, and retinoid acid on the malignant phenotype of human lung cancer cells, Int. J. Cancer 35:189 (1985).CrossRefGoogle Scholar
  41. 41.
    D. Pettijohn, C. Due and E. Rønne, Specific glycoproteins released by human squamous lung carcinoma cells: Characterization and diagnostic applications, J. Natl. Cancer Inst., in press.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • Lennart Olsson
    • 1
  • Claus Due
    • 1
  1. 1.Cancer Biology LaboratoryState University Hospital (Rigshospitalet)CopenhagenDenmark

Personalised recommendations